Survival and quality-of-life outcomes in early-stage NSCLC patients: a literature review of real-world evidence.

Pub Date : 2023-09-01 DOI:10.2217/lmt-2023-0003
Nick Jovanoski, Kathleen Bowes, Audrey Brown, Rossella Belleli, Danilo Di Maio, Shkun Chadda, Seye Abogunrin
{"title":"Survival and quality-of-life outcomes in early-stage NSCLC patients: a literature review of real-world evidence.","authors":"Nick Jovanoski,&nbsp;Kathleen Bowes,&nbsp;Audrey Brown,&nbsp;Rossella Belleli,&nbsp;Danilo Di Maio,&nbsp;Shkun Chadda,&nbsp;Seye Abogunrin","doi":"10.2217/lmt-2023-0003","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>Assess the long-term survival and quality-of-life outcomes in early-stage NSCLC (eNSCLC) patients.</p><p><strong>Methods: </strong>Review of long-term survival and quality-of-life after curative treatment in eNSCLC patients in observational studies.</p><p><strong>Results: </strong>Disease-free proportion decreased in stage III vs stage I patients. Recurrence-free proportion decreased with age and disease stage. Advanced stage and vascular invasion increased risk of late recurrence. Conditional 5-year relative survival rates did not exceed 87%, indicating higher mortality in eNSCLC survivors. Lower conditional survival rates and relative survival rates were associated with older age and advanced disease. Survivors of eNSCLC had poorer physical quality-of-life.</p><p><strong>Conclusion: </strong>Despite curative-intent therapy, survivors of eNSCLC still face significant risks of recurrence, excess mortality, and diminished quality-of-life.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/19/bb/lmt-12-60.PMC10485735.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/lmt-2023-0003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: Assess the long-term survival and quality-of-life outcomes in early-stage NSCLC (eNSCLC) patients.

Methods: Review of long-term survival and quality-of-life after curative treatment in eNSCLC patients in observational studies.

Results: Disease-free proportion decreased in stage III vs stage I patients. Recurrence-free proportion decreased with age and disease stage. Advanced stage and vascular invasion increased risk of late recurrence. Conditional 5-year relative survival rates did not exceed 87%, indicating higher mortality in eNSCLC survivors. Lower conditional survival rates and relative survival rates were associated with older age and advanced disease. Survivors of eNSCLC had poorer physical quality-of-life.

Conclusion: Despite curative-intent therapy, survivors of eNSCLC still face significant risks of recurrence, excess mortality, and diminished quality-of-life.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
早期非小细胞肺癌患者的生存和生活质量:现实世界证据的文献综述
目的:评估早期NSCLC (eNSCLC)患者的长期生存和生活质量。方法:回顾观察性研究中eNSCLC患者治愈治疗后的长期生存和生活质量。结果:与I期患者相比,III期患者无病比例下降。无复发率随年龄和疾病分期而降低。晚期和血管侵犯增加晚期复发的风险。有条件的5年相对生存率不超过87%,表明enclc幸存者的死亡率更高。较低的条件生存率和相对生存率与年龄较大和疾病晚期有关。enclc幸存者的身体生活质量较差。结论:尽管有治愈意图的治疗,eNSCLC的幸存者仍然面临着显著的复发、高死亡率和生活质量下降的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1